Oki Mark K
Chief Financial Officer at ACHV; SVP, CFO and Sec at Alexza Pharmaceuticals Inc.
- Sold, on record
- $198k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Sep 18, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ACHVACHIEVE LIFE SCIENCES, INC.Chief Financial Officer
- Alexza Pharmaceuticals Inc.SVP, CFO and Sec
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- ACHV50,060 shares
- Alexza Pharmaceuticals Inc.41,873 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Alexza Pharmaceuticals Inc.Plan not statedJun 6, 2012 2012
Sold 31,873 shares at $0.34 ($11k)
Oki Mark K, VP Fin Controller PAO PFO Sec
Sold 18.8% of holdings ($58k position)137,896 shares leftFirst sale on recordFiling
- 2 Form 4 sale Alexza Pharmaceuticals Inc.UnusualAug 27, 2012 +82 days
Sold 10,000 shares at $4.14 ($41k)
Oki Mark K, SVP, CFO and Sec
Sold 72.5% of holdings ($57k position)3,788 shares leftFiling
- 3 Form 4 sale ACHVUnusualSep 18, 2025 +4770 days
Sold 50,060 shares at $2.92 ($146k)
Oki Mark K, Chief Financial Officer
No 10b5-1 planSold 28.1% of holdings ($520k position)127,940 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Sep 22, 2025 | ACHV | Chief Financial Officer | Form 4 sale | 50,060 | $146k | 28.1% | Unusual | SEC |
| Aug 27, 2012 | Aug 29, 2012 | Alexza Pharmaceuticals Inc. | SVP, CFO and Sec | Form 4 sale | 10,000 | $41k | 72.5% | Unusual | SEC |
| Jun 6, 2012 | Jun 8, 2012 | Alexza Pharmaceuticals Inc. | VP Fin Controller PAO PFO Sec | Form 4 sale | 31,873 | $11k | 18.8% | Plan not stated | SEC |